Experimental · 5.3/10
Ephedrine
Ephedrine produces modest weight loss (about 0.9 kg/month per Shekelle 2003 JAMA) and a real ergogenic boost (+39% time-to-exhaustion in Bell 1998) but carries a multi-pathway multi-pathway intrinsic life-threatening risk profile: sudden cardiac death, stroke, heatstroke, and hypertensive crisis with MAOIs are documented at therapeutic doses. The 2004 FDA dietary-supplement ban remains in force. Read the full breakdown →
The prediction game
Where does Ephedrine go in 12 months?
Lock a call and say how sure you are. Right and confident earns the most; a leaderboard spot is the prize. No money, no stakes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Be the first scout on record for Ephedrine. Permanent credit on this page, plus points when your call resolves.
One call per intervention. It locks the moment you submit (no edits, no cancels) and resolves in 12 months. See the scout leaderboard →
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
Same as above — one verification covers all your entries here.
For education only, not medical advice. Supplements, peptides, and protocols can interact with medications and conditions. Talk to a qualified clinician before starting anything here.